Federation des caisses Desjardins du Quebec’s Supernus Pharmaceuticals SUPN Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,000	Closed	-$50.4K	–	2146
2018 Q3	$50.4K	Sell	1,000 -1,372	-58%	-$67.8K	﹤0.01%	1339
2018 Q2	$142K	Sell	2,372 -15,307	-87%	-$793K	﹤0.01%	1110
2018 Q1	$810K	Sell	17,679 -11,706	-40%	-$489K	0.01%	655
2017 Q4	$1.17M	Sell	29,385 -2,414	-8%	-$95.4K	0.02%	594
2017 Q3	$1.27M	Sell	31,799 -700	-2%	-$30.3K	0.02%	552
2017 Q2	$1.4M	Buy	32,499 +1,650	+5%	+$58.7K	0.02%	531
2017 Q1	$966K	Buy	+30,849	New	+$827K	0.02%	557

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's SUPN Position: Q4 2018 in Review

Federation des caisses Desjardins du Quebec sold out of Supernus Pharmaceuticals (SUPN) in Q4 2018, closing a stake of 1,000 shares — an estimated $50.4K sold.

Federation des caisses Desjardins du Quebec first reported a position in SUPN in Q1 2017 and held it in 7 quarters. The position peaked at $1.4M in Q2 2017. 274 funds tracked by Wall St. Rank hold SUPN as of Q4 2018.

Federation des caisses Desjardins du Quebec reported no remaining Supernus Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 1,000 Supernus Pharmaceuticals shares in Q4 2018, an estimated $50.4K.
Federation des caisses Desjardins du Quebec first reported a position in Supernus Pharmaceuticals in Q1 2017 and held it in 7 quarters.
Federation des caisses Desjardins du Quebec's Supernus Pharmaceuticals position peaked at $1.4M in Q2 2017.
274 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2018.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2018, filed 30 Aug 2024.